ACTIVE

Cancer Drug Development Forum

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result9,2 k €+183,7 %over 1 year
Gross margin300 k €+8,6 %over 1 year
Equity809,7 k €+1,1 %over 1 year

Identity

Source · BCE/KBO

Cancer Drug Development Forum is a Non-profit organization incorporated in 2019. Its main activity is: Activities of other membership organisations n.e.c.. Its registered office is in Woluwe-Saint-Lambert.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0738.523.752
Incorporation
28/11/2019
Legal form
Non-profit organization
Registered office
Clos Chapelle-aux-Champs 30
1200 Woluwe-Saint-Lambert · BruxellesSee on map
Latest accounts
31/12/2025
Joint committees (1)
  • 33700
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 4 filings

Trend over 3 financial years

202520242023
Income statement
Gross margin300 k €276,3 k €298,5 k €
EBITDA11,1 k €-10,5 k €37,1 k €
Operating result9,2 k €-12,5 k €34,5 k €
Net result9,2 k €-11 k €32,9 k €
Balance sheet
Equity809,7 k €800,6 k €811,5 k €
Total assets1,7 M €1,7 M €1,3 M €
Cash832,1 k €983,3 k €1 M €
Debts172,3 k €91,4 k €75,6 k €

Valuation

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

9 active · 9 ended

Active mandates

Axel Glasmacher

Trésorier · since 01 octobre 2025 · until 01 octobre 2028

Active
Elizabeth Ruth Plummer

Managing director · since 01 octobre 2025 · until 01 octobre 2028

Active
Jacob Verweij

Director · since 01 octobre 2025 · until 01 octobre 2028

Active
Mark Lawler

Chairman of the board of directors · since 01 octobre 2025 · until 01 octobre 2028

Active
Stefan Nicholas Symeonides

Vice-président du Conseil d'Administration · since 23 mai 2024 · until 23 mai 2027

Active
Christian Kornelius Schneider

Director · since 05 décembre 2023 · until 05 décembre 2026

Active
Fergus Loughlin Sweeney

Director · since 05 décembre 2023 · until 05 décembre 2026

Active
Rosa Giuliani

Director · since 05 décembre 2023 · until 05 décembre 2026

Active
Eva Catarina Edfjall

Director · since 30 mai 2023 · until 30 mai 2026

Active

Ended mandates

Stefan Nicholas Symeonides

Vice-chairman of the board of directors · since 23 mai 2024 · until 23 mai 2027

Ended
Elizabeth Ruth Plummer

Chairman of the board of directors · since 30 mai 2023 · until 30 mai 2026

Ended
Eva Skovlund

other_3 · since 30 mai 2023 · until 30 mai 2026

Ended
Eva Skovlund

Director · since 30 mai 2023 · until 24 mai 2024

Ended

Other companies at this address

Clos Chapelle-aux-Champs 30 1200 Woluwe-Saint-Lambert
CompanyCBE no.
ABDA LILLY● Active
0679.918.728
Acar'Up● Active
0567.583.523
ACCELERATE● Active
0733.539.041
ADGN● Active
0682.872.377
ALLERINVEST● Active
0644.917.069
astrohealth foundation● Active
1011.965.663
BELBABY● Active
0737.992.826
Belgian Society of Pediatric Heamatology-Oncology● Active
0457.785.857
Belgische Vereniging voor Medische, Informatica - Société belge d'Informatique médicale● Active
0414.282.743
BIOPHARMATEK● Active
0675.688.340
BRUSSELS LIFE SCIENCE INCUBATOR● Active
0899.602.447
CELLTEST● Active
0794.359.823
CENTRE CHAPELLE-AUX-CHAMPS● Active
0460.875.209
centre d'epidemiologie perinatale● Active
0892.776.419
Centre de Sante Universitaire de la Faculte de Medecine de l'Universite Catholique de Louvain (Section francophone)● Active
0409.122.244
Centre universitaire d'information sur les Professions médicales et-ou paramédicales● Active
0424.199.410
Conseil Etudiants de la Haute Ecole Léonard de Vinci● Active
0463.116.404
Data for Healthcare Improvement● Active
1008.075.864
EUROPEAN GERIATRIC MEDICINE SOCIETY● Active
0475.491.624
European Oncology Nursing Society● Active
0723.635.143

Full financial information

Source · NBB
202520242023
Type of accountMicro modelMicro modelMicro model
Start of the financial year01/01/202501/01/202401/01/2023
Closing of the financial year31/12/202531/12/202431/12/2023
Length of the financial year12 months12 months12 months
Filing date28/05/202628/05/202512/02/2025
General meeting18/05/202619/05/202523/05/2024
Currency of the financial yearEUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 4 filings
ModelClosingGeneral meetingFiledLanguageDocument
Micro model31/12/202518/05/202628/05/2026FrenchPDF
Micro model31/12/202419/05/202528/05/2025FrenchPDF
Micro modelCorrection31/12/202323/05/202412/02/2025FrenchPDF
Micro model31/12/202323/05/202404/12/2024FrenchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

9 active · 9 ended

Active mandates

Axel Glasmacher

Trésorier · since 01 octobre 2025 · until 01 octobre 2028

Active
Elizabeth Ruth Plummer

Managing director · since 01 octobre 2025 · until 01 octobre 2028

Active
Jacob Verweij

Director · since 01 octobre 2025 · until 01 octobre 2028

Active
Mark Lawler

Chairman of the board of directors · since 01 octobre 2025 · until 01 octobre 2028

Active
Stefan Nicholas Symeonides

Vice-président du Conseil d'Administration · since 23 mai 2024 · until 23 mai 2027

Active
Christian Kornelius Schneider

Director · since 05 décembre 2023 · until 05 décembre 2026

Active
Fergus Loughlin Sweeney

Director · since 05 décembre 2023 · until 05 décembre 2026

Active
Rosa Giuliani

Director · since 05 décembre 2023 · until 05 décembre 2026

Active
Eva Catarina Edfjall

Director · since 30 mai 2023 · until 30 mai 2026

Active

Ended mandates

Stefan Nicholas Symeonides

Vice-chairman of the board of directors · since 23 mai 2024 · until 23 mai 2027

Ended
Elizabeth Ruth Plummer

Chairman of the board of directors · since 30 mai 2023 · until 30 mai 2026

Ended
Eva Skovlund

other_3 · since 30 mai 2023 · until 30 mai 2026

Ended
Eva Skovlund

Director · since 30 mai 2023 · until 24 mai 2024

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Other26/08/2026
    Complément et rectification de l'extrait publié le 23 juillet 2026
    PDF
  • Mandates23/07/2026
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates04/12/2025
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates03/07/2025
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates09/04/2025
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates26/09/2024
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates22/05/2024
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates11/08/2023
    DEMISSIONS, NOMINATIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 20259,2 k €↑
  2. 2024
    Annual accounts 2024-11 k €↓
  3. 2023
    Annual accounts 202332,9 k €
  4. 28/11/2019
    IncorporationNon-profit organization